Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study.

Autor: Rahman, Mohummad A.1 (AUTHOR), Brekke, Jorunn1,2 (AUTHOR), Arnesen, Victoria1 (AUTHOR), Hannisdal, Marianne H.2 (AUTHOR), Navarro, Andrea G.1 (AUTHOR), Waha, Andreas3 (AUTHOR), Herfindal, Lars4 (AUTHOR), Rygh, Cecilie B.5 (AUTHOR), Bratland, Eirik6 (AUTHOR), Brandal, Petter7 (AUTHOR), Haasz, Judit5 (AUTHOR), Oltedal, Leif5 (AUTHOR), Miletic, Hrvoje8 (AUTHOR), Lundervold, Arvid1,5 (AUTHOR), Lie, Stein A.9 (AUTHOR), Goplen, Dorota2 (AUTHOR), Chekenya, Martha1 (AUTHOR) martha.chekenya@biomed.uib.no
Zdroj: Immunity, Inflammation & Disease. Sep2020, Vol. 8 Issue 3, p342-359. 18p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje